Adenosine receptors as therapeutic targets

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Neuroscience

Background:

• Adenosine receptors are key targets for caffeine, a widely consumed drug.
• Emerging evidence suggests their therapeutic potential in conditions including ischaemic diseases, sleep disorders, immune disorders, and cancer.

Purpose of the Study:

• To review recent advances in understanding adenosine receptor subtypes.
• To discuss the development of selective ligands for therapeutic applications.

Main Methods:

• Medicinal chemistry research over three decades.
• Discovery and clinical evaluation of adenosine receptor agonists and antagonists.
• Review of recent scientific literature on adenosine receptor modulators.

Main Results:

• Numerous selective adenosine receptor agonists and antagonists have been identified.
• Some developed ligands have undergone clinical evaluation.
• Understanding of adenosine receptor subtype roles has advanced significantly.

Conclusions:

• Despite no current regulatory approvals, therapeutic applications of adenosine receptor modulators are closer.
• Advances in selective ligand development and understanding of receptor subtypes are driving progress.